T0	Participants 327 383	completed RT in patients with head and neck cancer (HNC)
T1	Participants 435 495	Sixty-six consecutive patients from two RT clinics in Sweden
T2	Participants 1549 1599	CONCLUSIONS Patients with HNC undergoing high dose